China
0
Building 3, No.128 Jiu Jing Road
Add Favorite
Report Supplier
Business Description
Headquartered in Shanghai since 1997,with over 150 workforce and totally around 5,000 square meters state-of-art production facilities in China,3F Medical Systems is one of the best design and manufacturing services provider of medical and healthcare industry in China. 3F Medical Systems is an ISO13485 practicing manufacturer with SFDA registered facilities, which produces world-class products for the international market with required safety and regulatory approvals. 3F Medical Systems owns one manufacturing facilities in Shanghai China, and 4 additional trading offices in major cities in China. Our factory is ISO 9001, ISO 13485 standard certified. 3F Medical Systems is setting up its plant with electronic and mechanical engineering and manufacturing capabilities at the most competitive cost and lead time, which benefit stakeholders in a win-win manner. Having a corporate culture rooted in "Innovation & Quality", 3F Medical Systems' mission is to provide best quality products and integrated services, from design to manufacturing, at the most competitive costs and lead time, using continuous innovations in technology and management, to maximize shareholders' long-term value with balanced concern for all stakeholders.
Business Overview
Avg Response Time
≤ 1h
Export Capabilities
Declared by supplierShanghai 3F Medical System. has been exporting since 1997.
Export start year
1997
Trade Capabilities
Business Terms
Trade Ability
Patient Monitors market insight
Across Medical & HealthCare, the wider group Patient Monitors belongs to, Freshdi lists 9 active supply listings from 9 suppliers in 6 countries, as of 17 November 2026. Suppliers across Medical & HealthCare, the wider group Patient Monitors belongs to, come from 6 countries, led by India at 22.2%, on Freshdi as of 17 November 2026. In the 30 days to 17 November 2026, buyer inquiries on Freshdi across Medical & HealthCare, the group Patient Monitors belongs to, rose 100% against the 30 days before, with 103.41% volatility in monthly inquiry and quotation activity over 338 days.
